Crenigacestat (LY3039478)

98%

  • Product Code: 100208
  CAS:    1421438-81-4
Molecular Weight: 464.44 g./mol Molecular Formula: C₂₂H₂₃F₃N₄O₄
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20℃
Product Description: Crenigacestat is primarily investigated for its potential in cancer treatment, particularly targeting Notch signaling pathways. It is being studied in clinical trials for various cancers, including solid tumors and hematologic malignancies. The compound works by inhibiting gamma-secretase, an enzyme involved in the activation of Notch receptors, which play a key role in cancer cell proliferation and survival. Its application is focused on disrupting tumor growth and improving therapeutic outcomes, especially in cases where Notch signaling is dysregulated. Research continues to explore its efficacy and safety in combination with other anticancer therapies.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.005 10-20 days €296.09
+
-
Crenigacestat (LY3039478)
Crenigacestat is primarily investigated for its potential in cancer treatment, particularly targeting Notch signaling pathways. It is being studied in clinical trials for various cancers, including solid tumors and hematologic malignancies. The compound works by inhibiting gamma-secretase, an enzyme involved in the activation of Notch receptors, which play a key role in cancer cell proliferation and survival. Its application is focused on disrupting tumor growth and improving therapeutic outcomes, especially in cases where Notch signaling is dysregulated. Research continues to explore its efficacy and safety in combination with other anticancer therapies.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: €0.00
€0.00 Total :